title: Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease.
authors.forename: Mónica
authors.initials: M
authors.lastname: Ballesteros
authors.forename: Christelle
authors.initials: C
authors.lastname: Ferrá
authors.forename: David
authors.initials: D
authors.lastname: Serrano
authors.forename: Montserrat
authors.initials: M
authors.lastname: Batlle
authors.forename: Josep María
authors.initials: JM
authors.lastname: Ribera
authors.forename: José Luis
authors.initials: JL
authors.lastname: Díez-Martín
mesh_terms: D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004351:Drug Resistance / Q000187:drug effects*; D006086:Graft vs Host Disease / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality; D013256:Steroids / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D013256:Steroids